Advertisement
Screener

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Material Contracts, 2016

IOVANCE BIOTHERAPEUTICS, INC. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2016-11-04: Form 10-Q; Exhibit 10.5; Description Form of Indemnification Agreement.
  • 2016-11-04: Form 10-Q; Exhibit 10.3; Description Exclusive and Co-Exclusive License Agreement, dated September 14, 2016, between Lion Biotechnologies, Inc. and PolyBioCept AB.
  • 2016-10-03: Form 8-K; Exhibit 10.1; Description Executive Employment Agreement, dated September 28, 2016, by and among Lion Biotechnologies, Inc. and Gregory T. Schiffman..
  • 2016-08-09: Form 10-Q; Exhibit 10.3; Description Employment Agreement, dated June 1, 2016, between Lion Biotechnologies, Inc. and Maria Fardis, Ph.D.(2).
FiledFormExhibitDescription
2016-11-0410-Q10.5Form of Indemnification Agreement
2016-11-0410-Q10.3Exclusive and Co-Exclusive License Agreement, dated September 14, 2016, between Lion Biotechnologies, Inc. and PolyBioCept AB
2016-10-038-K10.1Executive Employment Agreement, dated September 28, 2016, by and among Lion Biotechnologies, Inc. and Gregory T. Schiffman.
2016-08-0910-Q10.3Employment Agreement, dated June 1, 2016, between Lion Biotechnologies, Inc. and Maria Fardis, Ph.D.(2)
2016-08-088-K10.1Office Lease, effective as of August 1, 2016, between Lion Biotechnologies, Inc. and Hudson Skyway Landing, LLC
2016-06-038-K10.5Form of Retention Bonus Agreement
2016-06-038-K10.4Board Adviser Agreement, dated June 1, 2016, between Lion Biotechnologies, Inc. and Dr. Elma Hawkins
2016-06-038-K10.3Severance Agreement and General Release, dated June 1, 2016, between Lion Biotechnologies, Inc. and Dr. Elma Hawkins
2016-06-038-K10.2Form of Registration Rights Agreement, dated June 2, 2016, by and among Lion Biotechnologies, Inc. and the Investors thereunder.
2016-06-038-K10.1Form of Securities Purchase Agreement, dated June 2, 2016, among Lion Biotechnologies, Inc. and the Investors thereunder
2016-05-0910-Q10.2Employment Agreement, dated March 28, 2016, between Lion Biotechnologies, Inc. and Michael T. Lotze, MD
2016-05-0910-Q10.1Employment Agreement, dated January 22, 2016, between Lion Biotechnologies, Inc. and Steven A. Fischkoff, MD

Similar stocks

Stock NameCountryMarket CapPE Ratio
Adaptive Biotechnologies Corp (ADPT)United States$4.719B-53.43
CRISPR Therapeutics AG (CRSP)$5.390B-11.68
Relay Therapeutics, Inc. (RLAY)United States$3.884B-14.30
Scholar Rock Holding Corp (SRRK)United States$5.920B-16.37
CG Oncology, Inc. (CGON)United States$6.095B-27.95
Tarsus Pharmaceuticals, Inc. (TARS)United States$3.329B-58.60
Denali Therapeutics Inc. (DNLI)United States$3.274B-8.04
Immunovant, Inc. (IMVT)United States$7.028B-14.78
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Greenland Mines Ltd (GRML)United States$2.362B